CAS 339086-80-5

Tadocizumab

CAS: 339086-80-5

Tadocizumab (C4G1) is a humanized monoclonal antibody targeting integrin αIIbβ3 with antiplatelet and antithrombotic effects.

Purity: 97.1% (SDS-PAGE); 97.2% (SEC-HPLC) - 97.1% (SDS-PAGE); 97.2% (SEC-HPLC)

Color and Shape: Transparent Liquid

Molecular weight: 47.59 kDa (Predicted)

Ref: TM-T76979

Tadocizumab

CAS: 339086-80-5

Purity: 95%

Molecular weight: G/Mol

Ref: IN-DA02EOBJ